Covalon Technologies Ltd (COV.V) Quote|
United States

Covalon Technologies Ltd (COV.V)

COV.V on TSX Venture Exchange

24 Jun 2016
Change (% chg)

$-0.03 (-2.36%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for COV.V


Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products intended for wound care, infection management and surgical procedures. The Company's wound care dressing products include ColActive Plus, ColActive Transfer, CovaWound Silicone, CovaWound Silicone Sacrum, CovaWound Foam, CovaWound... (more)
No analyst recommendations are available for COV.V.


Beta: 0.88
Market Cap(Mil.): $17.88
Shares Outstanding(Mil.): 14.42
Dividend: --
Yield (%): --


  COV.V Industry Sector
P/E (TTM): -- 30.47 34.11
EPS (TTM): -0.18 -- --
ROI: -30.31 8.47 14.23
ROE: -35.86 12.87 15.46

BRIEF-Covalon Technologies reports Q2 loss per share of C$0.10

* Q2 loss per share C$0.10 Source text for Eikon: Further company coverage:

May 30 2016

BRIEF-Covalon sees products cleared in 8 countries by 2016 end

* Expects to have its products cleared in Mexico, Colombia, Peru, Venezuela, Ecuador, Dominican Republic, Paraguay And Uruguay by end of 2016

May 19 2016

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : Wright Reports
Provider : GlobalData
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.